Skip to main content

MannKind Corp (MNKD) Stock

MannKind Corp Stock Details, Movements and Public Alerts

Stock Details

MannKind Corp (MNKD), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $5.60. Over the past 52 weeks, it has ranged between $3.38 and $7.63. This places the current price at 73.4% of its 52-week high and 65.7% above its 52-week low. 0The 14-day Relative Strength Index (RSI) stands at 57.58, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $5.30 by 5.66%. Similarly, it is above its 200-day moving average of $4.79 by 16.91%. The MACD histogram is 0.01, indicating bullish momentum (MACD Line: 0.07, Signal Line: 0.07). There are currently 3 active alerts set for MNKD by users.

52-Week Range

$7.63 - $3.38

-26.61% from high · +65.68% from low

Avg Daily Volume

4,648,192

20-day average

100-day avg: 4,096,421

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

50.82

Above market average

Forward P/E

34.36

Earnings expected to grow

PEG Ratio

-0.23

Potentially undervalued

EV/EBITDA

19.62

EPS (TTM)

$0.11

Price to Sales

5.68

Beta

1.08

Similar volatility to market

How is MNKD valued relative to its earnings and growth?
MannKind Corp trades at a P/E ratio of 50.82, which is above the market average of approximately 20. This premium valuation suggests investors expect above-average growth or the company has competitive advantages justifying the higher multiple. Looking ahead, the forward P/E of 34.36 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of -0.23 suggests the stock may be undervalued relative to its growth rate.
What is MNKD's risk profile compared to the market?
With a beta of 1.08, MannKind Corp is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility.

Performance & Growth

Profit Margin

10.90%

Operating Margin

13.90%

EBITDA

$81.21M

Return on Equity

0.00%

Return on Assets

10.60%

Revenue Growth (YoY)

5.70%

Earnings Growth (YoY)

8.90%

How profitable and efficient is MNKD's business model?
MannKind Corp achieves a profit margin of 10.90%, meaning it retains $10.90 from every $100 in revenue after all expenses. This represents a solid margin typical of well-run businesses, showing the company can effectively balance revenue generation with cost control. The operating margin of 13.90% reveals how efficiently the company runs its core business operations before interest and taxes.0
What are MNKD's recent growth trends?
MannKind Corp's revenue grew by 5.70% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings increased by 8.90% year-over-year, outpacing revenue growth through improved margins. These growth metrics should be evaluated against BIOTECHNOLOGY industry averages for proper context.

Company Size & Market

Market Cap

$1.7B

Revenue (TTM)

$301.74M

Revenue/Share (TTM)

$1.04

Shares Outstanding

306.83M

Book Value/Share

-$0.18

Asset Type

Common Stock

What is MNKD's market capitalization and position?
MannKind Corp has a market capitalization of $1.7B, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 306.83M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
How does MNKD's price compare to its book value?
MannKind Corp's book value per share is -$0.18, while the current stock price is $5.60, resulting in a price-to-book (P/B) ratio of -31.11. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$10.38

85.36% upside potential

Analyst Recommendations

Strong Buy

2

Buy

5

Hold

0

Sell

0

Strong Sell

0

How reliable are analyst predictions for MNKD?
7 analysts cover MNKD with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $10.38 implies 85.4% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on MNKD?
Current analyst recommendations:2 Strong Buy, 5 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Nov 2, 2025, 03:05 PM

Technical Indicators

RSI (14-day)

57.58

Neutral

50-Day Moving Average

$5.30

5.66% above MA-50

200-Day Moving Average

$4.79

16.91% above MA-200

MACD Line

0.07

MACD Signal

0.07

MACD Histogram

0.01

Bullish

What does MNKD's RSI value tell investors?
The RSI (Relative Strength Index) for MNKD is currently 57.58, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
How should traders interpret MNKD's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.07 below the signal line at 0.07, with histogram at 0.01. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($5.30) is above the 200-day MA ($4.79), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Nov 3, 2025, 12:33 AM

Active Alerts

Alert Condition
RSI Threshold Cross
Threshold
59
Created
Nov 2, 2025, 03:05 PM
Alert Condition
MA Breakout (Bearish)
Threshold
200 days
Created
Nov 2, 2025, 03:05 PM
Alert Condition
Forward P/E falls below
Threshold
32 x
Created
Nov 2, 2025, 03:05 PM

Stay Ahead of the Market with MannKind Corp Alerts

Set up price alerts for MannKind Corp and get notified instantly when the price hits your target. Never miss an important price movement again.